Prognostic value of preoperative platelet-lymphocyte and neutrophil-lymphocyte ratio in patients undergoing surgery for esophageal squamous cell cancer

Diseases of the Esophagus

Volumn 29, Issue 1, 2016, Pages 79-85

  Xie, X ^a   Luo, K J ^b   Hu, Y ^b   Wang, J Y ^b   Chen, J ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

Author keywords

Esophageal cancer; Inflammation; Outcome; Systemic; Tumor marker

Indexed keywords

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CORRELATION ANALYSIS; DISEASE SPECIFIC SURVIVAL; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS RESECTION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL LYMPHOCYTE RATIO; PLATELET LYMPHOCYTE RATIO; PREDICTIVE VALUE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; REFERENCE VALUE; ADVERSE EFFECTS; BLOOD; BLOOD CELL COUNT; CARCINOMA, SQUAMOUS CELL; CHINA; EPIDEMIOLOGY; ESOPHAGEAL NEOPLASMS; INFLAMMATION; LYMPHOCYTE; MIDDLE AGED; MORTALITY; NEUTROPHIL; PATHOLOGY; PATHOPHYSIOLOGY; PREOPERATIVE PERIOD; PROCEDURES; PROGNOSIS; RETROSPECTIVE STUDY; STATISTICS AND NUMERICAL DATA; SURVIVAL ANALYSIS; THROMBOCYTE; TREATMENT OUTCOME;

BLOOD CELL COUNT; BLOOD PLATELETS; CARCINOMA, SQUAMOUS CELL; CHINA; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; HUMANS; INFLAMMATION; LYMPHOCYTES; MALE; MIDDLE AGED; NEUTROPHILS; PREDICTIVE VALUE OF TESTS; PREOPERATIVE PERIOD; PROGNOSIS; RETROSPECTIVE STUDIES; ROC CURVE; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84954517948     PISSN: 11208694     EISSN: 14422050     Source Type: Journal    
DOI: 10.1111/dote.12296     Document Type: Article

References (34)

1. Ferlay J, Shin H R, Bray F, Forman D, Mathers C, Parkin D M. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010; 127: 2893-2917.
2. Jemal A, Bray F, Center M M, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011; 61: 69-90.
3. Sjoquist K M, Burmeister B H, Smithers B M etal. Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis. Lancet Oncol 2011; 12: 681-692.
4. Rice T W, Blackstone E H, Rusch V W. 7th edition of the AJCC Cancer Staging Manual: esophagus and esophagogastric junction. Ann Surg Oncol 2010; 17: 1721-1724.
5. Tachibana M, Hirahara N, Kinugasa S, Yoshimura H. Clinicopathologic features of superficial esophageal cancer: results of consecutive 100 patients. Ann Surg Oncol 2008; 15: 104-116.
6. Ancona E, Rampado S, Cassaro M etal. Prediction of lymph node status in superficial esophageal carcinoma. Ann Surg Oncol 2008; 15: 3278-3288.
7. Lee P C, Port J L, Paul S, Stiles B M, Altorki N K. Predictors of long-term survival after resection of esophageal carcinoma with nonregional nodal metastases. Ann Thorac Surg 2009; 88: 186-192.
8. Coussens L M, Werb Z. Inflammation and cancer. Nature 2002; 420: 860-867.
9. DeNardo D G, Johansson M, Coussens L M. Immune cells as mediators of solid tumor metastasis. Cancer Metastasis Rev 2008; 27: 11-18.
10. Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow? Lancet 2001; 357: 539-545.
11. O'Dowd C, McRae L A, McMillan D C, Kirk A, Milroy R. Elevated preoperative C-reactive protein predicts poor cancer specific survival in patients undergoing resection for non-small cell lung cancer. J Thorac Oncol 2010; 5: 988-992.
12. Miki C, Tanaka K, Toiyama Y etal. Comparison of the prognostic value of inflammation-based pathologic and biochemical criteria in patients undergoing potentially curative resection for colorectal cancer. Ann Surg 2010; 251: 389-390.
13. Mohri Y, Tanaka K, Ohi M, Yokoe T, Miki C, Kusunoki M. Prognostic significance of host- and tumor-related factors in patients with gastric cancer. World J Surg 2010; 34: 285-290.
14. Asher V, Lee J, Bali A. Preoperative serum albumin is an independent prognostic predictor of survival in ovarian cancer. Med Oncol 2012; 29: 2005-2009.
15. Shimada H, Nabeya Y, Okazumi S etal. Elevation of preoperative serum C-reactive protein level is related to poor prognosis in esophageal squamous cell carcinoma. J Surg Oncol 2003; 83: 248-252.
16. Nozoe T, Saeki H, Sugimachi K. Significance of preoperative elevation of serum C-reactive protein as an indicator of prognosis in esophageal carcinoma. Am J Surg 2001; 182: 197-201.
17. Ikeda M, Natsugoe S, Ueno S, Baba M, Aikou T. Significant host- and tumor-related factors for predicting prognosis in patients with esophageal carcinoma. Ann Surg 2003; 238: 197-202.
18. Hauser C A, Stockler M R, Tattersall M H. Prognostic factors in patients with recently diagnosed incurable cancer: a systematic review. Support Care Cancer 2006; 14: 999-1011.
19. Walsh S R, Cook E J, Goulder F, Justin T A, Keeling N J. Neutrophil-lymphocyte ratio as a prognostic factor in colorectal cancer. J Surg Oncol 2005; 91: 181-184.
20. Kwon H C, Kim S H, Oh S Y etal. Clinical significance of preoperative neutrophil-lymphocyte versus platelet-lymphocyte ratio in patients with operable colorectal cancer. Biomarkers 2012; 17: 216-222.
21. Yamanaka T, Matsumoto S, Teramukai S, Ishiwata R, Nagai Y, Fukushima M. The baseline ratio of neutrophils to lymphocytes is associated with patient prognosis in advanced gastric cancer. Oncology 2007; 73: 215-220.
22. Sarraf K M, Belcher E, Raevsky E, Nicholson A G, Goldstraw P, Lim E. Neutrophil/lymphocyte ratio and its association with survival after complete resection in non-small cell lung cancer. J Thorac Cardiovasc Surg 2009; 137: 425-428.
23. Asher V, Lee J, Innamaa A, Bali A. Preoperative platelet lymphocyte ratio as an independent prognostic marker in ovarian cancer. Clin Transl Oncol 2011; 13: 499-503.
24. Rashid F, Waraich N, Bhatti I etal. A pre-operative elevated neutrophil: lymphocyte ratio does not predict survival from oesophageal cancer resection. World J Surg Oncol 2010; 8: 1.
25. Dutta S, Crumley A B, Fullarton G M, Horgan P G, McMillan D C. Comparison of the prognostic value of tumour- and patient-related factors in patients undergoing potentially curative resection of oesophageal cancer. World J Surg 2011; 35: 1861-1866.
26. Sharaiha R Z, Halazun K J, Mirza F etal. Elevated preoperative neutrophil: lymphocyte ratio as a predictor of postoperative disease recurrence in esophageal cancer. Ann Surg Oncol 2011; 18: 3362-3369.
27. Smith R A, Bosonnet L, Raraty M etal. Preoperative platelet-lymphocyte ratio is an independent significant prognostic marker in resected pancreatic ductal adenocarcinoma. Am J Surg 2009; 197: 466-472.
28. Shimada H, Oohira G, Okazumi S etal. Thrombocytosis associated with poor prognosis in patients with esophageal carcinoma. J Am Coll Surg 2004; 198: 737-741.
29. Honn K V, Tang D G, Crissman J D. Platelets and cancer metastasis: a causal relationship? Cancer Metastasis Rev 1992; 11: 325-351.
30. Salazar-Onfray F, Lopez M N, Mendoza-Naranjo A. Paradoxical effects of cytokines in tumor immune surveillance and tumor immune escape. Cytokine Growth Factor Rev 2007; 18: 171-182.
31. Xin Z, Wenyu F, Shenhua X. Clinicopathologic significance of cytokine levels in esophageal squamous cell carcinoma. Hepatogastroenterology 2010; 57: 1416-1422.
32. Fukai Y, Fukuchi M, Masuda N etal. Reduced expression of transforming growth factor-beta receptors is an unfavorable prognostic factor in human esophageal squamous cell carcinoma. Int J Cancer 2003; 104: 161-166.
33. Fukuchi M, Miyazaki T, Fukai Y etal. Plasma level of transforming growth factor beta1 measured from the azygos vein predicts prognosis in patients with esophageal cancer. Clin Cancer Res 2004; 10: 2738-2741.
34. Michiels S, Koscielny S, Hill C. Prediction of cancer outcome with microarrays: a multiple random validation strategy. Lancet 2005; 365: 488-492.